Eliza Corporation ("Eliza"), the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System. The patent for the Complex Acoustic Resonance Speech Analysis System will be Eliza's fifteenth U.S. patent. Eliza's intellectual property covers a range of speech recognition technology (SRT), linguistic technology and high-performance interaction networks. The patent issuance for the Complex Acoustic Resonance Speech Analysis System is an important addition to Eliza's growing patent portfolio, and underscores Eliza's non-stop dedication to delivering innovative technologies that address the opportunities and challenges in the healthcare space – today and in the future.
"Our growth and leadership in the Health Engagement Management market is powered by our continuous technology invention," said Lucas Merrow, Founder and CEO of Eliza Corporation. "Eliza's patented technology enables us to deliver relevant, timely content through interactions that are incredibly lifelike, based on data-driven segmentation. These conversations are a key element to our "surround-sound" approach – coordinated, multi-modal outreach that lets us carefully monitor engagement across all channels, meet people where they are in their healthcare experience and connect them with the resources they need to make better health-related decisions."
The Complex Acoustic Resonance Speech Analysis System further advances Eliza's industry-leading technology in simulating one-to-one human interactions. Conversational, high-performance speech recognition is fundamental to engaging consumers with automated interactions in healthcare. Eliza's unmatched linguistics-based engine understands a wide range of responses – so people can respond naturally and focus on the topic at hand – not detailed menus or usage instructions. As a result, the flexible interface translates to more effective interactions delivered at a scale that makes Eliza appropriate for all sizes of member populations. Eliza's technology also: